Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
99 Leser
Artikel bewerten:
(0)

Eveo Ranked #1 Independent Digital Healthcare Agency in U.S. 2nd Year in a Row

SAN FRANCISCO, May 16, 2011 /PRNewswire/ -- For the second year in a row, Advertising Age recognized Eveo Communication Group (www.eveo.com) as the #1 Independent Digital Healthcare Agency in the U.S. Eveo also advanced another front in the annual Ad Age rankings, making the Top 25 Healthcare Agency list for the first time.

(Photo: http://photos.prnewswire.com/prnh/20110516/SF03150)

(Logo: http://photos.prnewswire.com/prnh/20100630/SF29260LOGO-a)

"Ranking #1 Independent Digital Healthcare Agency in the U.S. is a testament to the dedication and innovation of the Eveo team, and to the result-oriented partnerships we have developed with our clients," said Olivier Zitoun, Eveo's CEO.

Joining the Top 25 Healthcare Agency list for the first time, Eveo accompanies healthcare agencies, of all disciplines, not just digital. Not surprising as Ad Age quotes 28% of the portion of U.S. agency revenue came from digital services in 2010. As the second agency on the Top 25 Healthcare Agency list as a digital healthcare firm, Eveo predicts climbing the list in the years to come, surpassing the traditional long-standing healthcare agencies that are not exclusively digital.

The two Ad Age distinctions for 11-year-old Eveo can be seen as a direct result of the agency's investments made last year to further its capabilities in strategy, creative, and technology. Eveo formed 3 subsidiary studios to develop advanced technology solutions by discipline: Mobile (EV2), interactive/web/tradeshow (EVi), and animation/video/visual effects (EVLab). EV2, with 40 mobile applications currently in development, has recently gained attention for its innovative iPad Digital Selling Platform. To date, the three studios have collectively earned over 112 industry awards for their powerful healthcare communication solutions.

The 67th annual Advertising Agency rankings appeared in Ad Age's edition released on April

25, 2011. It includes rankings of more than 900 advertising, marketing services, and media agencies based on 2010 revenue. The report is available online at www.adage.com.

About Eveo

For innovative e-marketing strategies and powerful digital solutions, the world's leading pharmaceutical, biotech and medical device companies turn to Eveo, the #1 Independent Digital Healthcare Agency in the U.S. Headquartered in San Francisco, Eveo's award winning team has a variety of skills and one shared passion: innovation. At Eveo, 3D artists, digital designers and technology leaders work alongside scientists, PhDs and MDs to develop e-marketing strategies that are as inventive as they are effective. The agency has a staff of over 200, with dedicated in-house production studios and field offices in Chicago, New York, New Jersey and Philadelphia. Eveo is redefining the e in e-marketing. Visit: www.eveo.com

Media Contact:
Sonya More'
smore@eveo.com
415 749 6777 x171

SOURCE Eveo

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.